New ACIP Adult Immunization Schedule recommends changes to several vaccines, includes interim recomm

February 11, 2021

Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.

New ACIP Adult Immunization Schedule recommends changes to several vaccines, includes interim recommendation for COVID-19 vaccination
Revised content based on updated ACIP recommendations published since October, 2019.
Abstract: http://annals.org/aim/article/doi/10.7326/M20-8080
URL goes live when the embargo lifts

The Advisory Committee on Immunization Practices (ACIP) has released its 2021 Recommended Adult Immunization Schedule that includes changes to several vaccines including influenza, hepatitis A, human papillomavirus (HPV); and the measles, mumps and rubella (MMR) vaccine. The schedule also includes interim recommendations for COVID-19 vaccination. The complete schedule, including changes in the vaccine notes section, is being simultaneously published in Annals of Internal Medicine and on the Centers for Disease Control and Prevention (CDC) web site.

In October 2020, ACIP voted to approve the Recommended Adult Immunization Schedule for Ages 19 Years or Older, United States, 2021. Following Emergency Use Authorization of Pfizer-BioNTech COVID-19 vaccine by the Food and Drug Administration, ACIP issued an interim recommendation at its December 12, 2020, emergency meeting for use of Pfizer-BioNTech COVID-19 vaccine in persons age 16 years or older. In addition, ACIP approved an amendment to include COVID-19 vaccine recommendations in the child and adolescent immunization schedules. Following Emergency Use Authorization of Moderna COVID-19 vaccine by the Food and Drug Administration, ACIP issued an interim recommendation at its December 19, 2020, emergency meeting for use of Moderna COVID-19 vaccine in persons age 18 years or older. According to the authors, it is important for all adults to receive recommended immunizations and catch-up vaccines, even when wearing masks and following personal hygiene and social distancing measures. As such, the 2021 schedule includes a special section addressing vaccination during the COVID-19 pandemic.

The schedule, which can be complex and challenging to implement, features revised content, and has been harmonized with the Child and Adolescent Immunization Schedule.

The adult immunization schedule is published annually to consolidate and summarize updates to ACIP recommendations on vaccination of adults and to assist health care providers in implementing current ACIP recommendations. The authors note that physicians should pay careful attention to the details found in the vaccine notes section, as they clarify who needs what vaccine, when, and at what dose.

Media contacts:

For an embargoed PDF please contact Lauren Evans at laevans@acponline.org.

To speak with the lead author, Mark Freedman, DVM, MPH, please contact him directly at fll0@cdc.gov.
-end-


American College of Physicians

Related Vaccination Articles from Brightsurf:

US adults' likelihood of accepting COVID-19 vaccination
In this survey study of U.S. adults, vaccine-related attributes and political characteristics were associated with self-reported preferences for choosing a hypothetical COVID-19 vaccine and self- reported willingness to receive vaccination.

Vaccination insights
While scientists race to develop and test a vaccine effective against SARS-CoV-2, the virus that causes COVID-19, recent studies have indicated that countries with widespread BCG vaccination appear to be weathering the pandemic better than their counterparts.

Wording of vaccination messages influences behavior
An experiment by Washington State University researchers revealed that relatively small differences in messages influenced people's attitudes about the human papillomavirus or HPV vaccine, which has been shown to help prevent cancer.

Addressing HPV vaccination concerns
Research from the Harvard Pilgrim Health Care Institute finds a promising avenue for addressing vaccine hesitancy around HPV vaccine.

Virtual reality could help flu vaccination rates
Using a virtual reality simulation to show how flu spreads and its impact on others could be a way to encourage more people to get a flu vaccination, according to a study by researchers at the University of Georgia and the Oak Ridge Associated Universities in Oak Ridge, Tennessee.

Religion associated with HPV vaccination rate for college women
A survey of female college students finds 25% had not been vaccinated for HPV and religion may be a contributing factor.

Measles vaccination: 'All for one and one for all'
A commentary by researchers addresses the specter of clinical, ethical, public health and legal concerns that have been raised because of the recent measles outbreaks in New York.

New single vaccination approach to killer diseases
Scientists from the University of Adelaide's Research Centre for Infectious Diseases have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections, the world's most deadly respiratory diseases.

Vaccination may help protect bats from deadly disease
A new study shows that vaccination may reduce the impact of white-nose syndrome in bats, marking a milestone in the international fight against one of the most destructive wildlife diseases in modern times.

Parents reassured febrile seizures following vaccination not dangerous
New University of Sydney research finds that febrile seizures after vaccination are rare, not serious and are no different to febrile seizures due to other causes such as from a virus.

Read More: Vaccination News and Vaccination Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.